Forte Biosciences FBRX
FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Asset Utilization Ratio (2018 - 2019)

Updated

Forte Biosciences' (FBRX) Asset Utilization Ratio came in at 0.00 for Q4 2019, down 99.5% from 0.19 a year earlier but up 98.9% from the prior quarter.

Analysis

Forte Biosciences (FBRX) Asset Utilization Ratio (2018 - 2019) Analysis & Trends

Since Q1 2018, Forte Biosciences has reported Asset Utilization Ratio for 8 quarters.

  • In prior years, Forte Biosciences' Asset Utilization Ratio was 0.18 in FY2018 and 0.00 in FY2017.
  • Quarterly Asset Utilization Ratio has run from a low of 0.00 in Q1 2018 to a high of 0.20 in Q3 2018 over five years.
  • According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.00 (Q3 2019), 0.20 (Q2 2019) and 0.18 (Q1 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.49
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.47
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.52
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.44
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.53
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.58
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 0.47
10 Forte Biosciences 1.58 Bn 1.38 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 0.00
Sep 30, 2019 0.00
Jun 30, 2019 0.20
Mar 31, 2019 0.18
Dec 31, 2018 0.19
Sep 30, 2018 0.20
Jun 30, 2018 0.00
Mar 31, 2018 0.00
API Access

Forte Biosciences Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=FBRX&period=max&api_key=YOUR_API_KEY